Evidence map›Paper›PMID 31692839›Full record

ArticleThe Pan African medical journal2019

[Digestives diseases associated to sickle cell anemia in Lubumbashi: epidemiological and clinical aspects].

Manix Ilunga Banza, Jules Panda Mulefu, Lire Ipani Lire, Yannick Tietie Ben N'dwala, Israel Badypwyla Tshiamala, Vincent de Paul Kaoma Cabala

Open access · greenAbstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Manix Ilunga BanzaUniversité de Lubumbashi, Faculté de Médecine, Département de Chirurgie, Cliniques Universitaires de Lubumbashi, Lubumbashi, République Démocratique du Congo.
Jules Panda MulefuUniversité de Lubumbashi, Faculté de Médecine, Département de Chirurgie, Cliniques Universitaires de Lubumbashi, Lubumbashi, République Démocratique du Congo.
Lire Ipani LireUniversité de Lubumbashi, Faculté de Médecine, Département de Chirurgie, Cliniques Universitaires de Lubumbashi, Lubumbashi, République Démocratique du Congo.
Yannick Tietie Ben N'dwalaUniversité de Lubumbashi, Faculté de Médecine, Département de Chirurgie, Cliniques Universitaires de Lubumbashi, Lubumbashi, République Démocratique du Congo.
Israel Badypwyla TshiamalaUniversité de Lubumbashi, Faculté de Médecine, Département de Chirurgie, Cliniques Universitaires de Lubumbashi, Lubumbashi, République Démocratique du Congo.
Vincent de Paul Kaoma CabalaUniversité de Lubumbashi, Faculté de Médecine, Département de Chirurgie, Cliniques Universitaires de Lubumbashi, Lubumbashi, République Démocratique du Congo.
University of Lubumbashi · CD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionsickle cell disease is a genetic disease with autosomal inheritance associated with haemoglobin structure abnormality which causes the formation of hemoglobin S. The purpose of our study was to collect data on digestive diseases in patients with sickle cell disease in Lubumbashi and to highlight their epidemiological and clinical features.

methodsWe conducted a retrospective, descriptive, cross-sectional study at the Research Center for Sickle Cell Disease in Lubumbashi. All the records of patients on follow-up for sickle cell disease with digestive disease during our 3-year period (January 2015 to December 2017) were analyzed. Data were collected using a survey taking into account different study parameters including: age, sex, the reason for consultation, diagnosis, the type of vaso-occlusive crisis, the paraclinical examinations made, hydroxyurea treatment.

resultsout of a total of 403 medical records examined we found 206 cases (n=206) of sickle cell disease associated with digestive disease, accounting for a rate of 51,11% of patients with sickle cell disease who suffered from digestive diseases. Both sexes were represented with a slight female predominance (51.94%) and a sex ratio M/F of 0.92. The most represented age ranges 1-6 years (32.52%), the average age was 11.8 years; the standard deviation was 21.9; the extreme ages were 13 months and 38 years. The reason for consultation was dominated by fever (60,67%), abdominal pain (44.66%) and digestive disorders (30,09%). Vaso-occlusive abdominal crises were found in 65 patients (31.55%) among whom 36 had only 1 crisis, 24 had 2 crises and 5 had 3 crises. Intestinal diseases were found in 121 patients (69,41%) dominated by intestinal parasites (found in 58 patients whose collection of stool samples showed 4 parasites: Yersinia enterocolitis, Entamoeba histolytica, Giardia intestinalis and Clostridium difficile). Gastric diseases were found in 105 patients ( 50,97%) divided into peptic ulcer (45 patients) and gastritis (60 patients); biliary vesicular disease was found in 40 patients (19.41%) including vesicular lithiasis without cholecystitis (32 patients), lithiasic cholecystitis (5 patients) and lithiasis in the main biliary tract (3 cases); there was 1 single case diagnosed with acute pancreatitis. The most common associated diseases in our study were respiratory diseases (169 cases;82,03%), oto-rhino-laryngological diseases (157 cases;76.21%), bony, vaso-occlusive crises (146 cases; 70,87%), urogenital diseases (64 cases; 31.06%) and malaria (51 patients; 24.75%). Hepatic diseases and diseases of the spleen were found in 18 cases (8.73%) and 47 cases (22,81%) respectively. Ultrasound was requested in 79 patients but only 31 of them underwent it because of the lack of financial means (it costs 20 U.S. dollars). In the case of clinically obvious splenomegaly, the search for Howell-Jolly bodies was requested in 23 patients but it was only performed in 2 patients because it costs 10 U.S. dollars). Routine blood count, hemoglobin, hematocrit, inflammatory assessment and thick drop examination were performed in all our patients but liver assessment, tests done on stool samples, urine test were recommended based on patient's complaint. Out of 206 patients, only 60 were under hydroxyurea treatment (29,16%).

conclusiondigestive diseases are common in patients with sickle cell disease and account for almost half of patients with diagnosed sickle cell disease. Unfortunately, best management is limited by poverty leading to less very useful paraclinical examinations in patients with digestive diseases resulting from sickle cell disease.

Indexed as

Abdominal PainAdolescentAdultAnemia, Sickle CellChildChild, PreschoolCross-Sectional StudiesDemocratic Republic of the CongoDigestive System DiseasesFemaleHumansHydroxyureaInfantMaleRetrospective StudiesSplenomegalyHydroxyureadigestive diseasefrequencySickle cell disease

Identifiers

PMID31692839
PMCPMC6814946
OpenAlexW2965867182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.